Insecticides India Ltd
NSE: INSECTICID BSE: 532851
₹746.15
(1.69%)
Mon, 25 May 2026, 03:38 pm
Market Cap22.17B
PE Ratio15.33
Dividend0.26
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
Insecticides India Analysis
dividend
Pros
- Dividends per share have increased over the past 10 years.
- Dividends paid are thoroughly covered by earnings (29.7x coverage).
- Insecticides (India)'s pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Cons
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Insecticides (India)'s dividend is below the markets top 25% of dividend payers in India (3.08%).
health
Pros
- Insecticides (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Insecticides (India) is profitable, therefore cash runway is not a concern.
- Insecticides (India) is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 3.6x debt.
- Insecticides (India)'s cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (112.6% vs 40.4% today).
- Interest payments on debt are well covered by earnings (EBIT is 7.8x coverage).
Cons
- Operating cash flow is negative therefore debt is not well covered.
- Insecticides (India)'s level of debt (40.4%) compared to net worth is high (greater than 40%).
- High level of physical assets or inventory.
management
Pros
- The tenure for the Insecticides (India) board of directors is about average.
- The average tenure for the Insecticides (India) management team is over 5 years, this suggests they are a seasoned and experienced team.
Cons
- Rajesh's remuneration is higher than average for companies of similar size in India.
- Rajesh's compensation has increased by more than 20% in the past year whilst earnings grew less than 20%.
misc
Pros
Cons
- Insecticides (India) is not covered by any analysts.
- Insecticides (India) has significant price volatility in the past 3 months.
past
Pros
- Insecticides (India) has delivered over 20% year on year earnings growth in the past 5 years.
- Insecticides (India) used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Insecticides (India) has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Cons
- Insecticides (India)'s 1-year earnings growth is less than its 5-year average (8.2% vs 22.1%)
- Insecticides (India) has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Insecticides (India)'s earnings growth has not exceeded the IN Chemicals industry average in the past year (8.2% vs 9.1%).
value
Pros
- Insecticides (India) is good value based on earnings compared to the IN Chemicals industry average.
- Insecticides (India) is good value based on earnings compared to the India market.
- BSE:532851 is up 22% outperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:532851 is up 22% outperforming the market in India which returned 8% over the past month.
Cons
- Insecticides (India)'s share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Insecticides (India)'s share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Insecticides (India) is overvalued based on assets compared to the IN Chemicals industry average.
- 532851 underperformed the Chemicals industry which returned 2.2% over the past year.
- 532851 underperformed the Market in India which returned -14.5% over the past year.